Status:
COMPLETED
Metformin Versus Insulin in Gestational Diabetes
Lead Sponsor:
Turku University Hospital
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
Gestational diabetes is traditionally treated with insulin. Metformin is a peroral drug used worldwide in the treatment of type 2 diabetes and also in a few studies on patients with gestational diabet...
Detailed Description
Gestational diabetes is traditionally treated with insulin. Metformin is a peroral drug used worldwide in the treatment of type 2 diabetes and also in a few studies on patients with gestational diabet...
Eligibility Criteria
Inclusion
- Mothers with gestational diabetes who had at least twice plasma glucose at fasting \> 5.4 mmol/L and/or 1 hour postprandial value \> 7.7 mmol/L at 24 to 32 gestational weeks
Exclusion
- Fasting glucose \> 7.0 mmol/L or 1 hour postprandial plasma glucose \> 11.0 mmol/L or Glycosylated hemoglobin A1c (HbA1c) \> 7.0%
- Renal, hepatic or cardiac failure
- Pregestational use of metformin
- Pregnancy with multiple fetuses
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT01240785
Start Date
June 1 2006
End Date
December 1 2012
Last Update
November 24 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.